Intravascular imaging assessment of pharmacotherapies targeting atherosclerosis: advantages and limitations in predicting their prognostic implications
V Tufaro, PW Serruys, L Räber… - Cardiovascular …, 2023 - academic.oup.com
Intravascular imaging has been often used over the recent years to examine the efficacy of
emerging therapies targeting plaque evolution. Serial intravascular ultrasound, optical …
emerging therapies targeting plaque evolution. Serial intravascular ultrasound, optical …
High-risk morphological and physiological coronary disease attributes as outcome markers after medical treatment and revascularization
Objectives This study sought to evaluate the prognostic impact of plaque morphology and
coronary physiology on outcomes after medical treatment or percutaneous coronary …
coronary physiology on outcomes after medical treatment or percutaneous coronary …
Regression of coronary fatty plaque and risk of cardiac events according to blood pressure status: data From a randomized trial of eicosapentaenoic acid and …
FK Welty, E Hariri, AA Asbeutah, R Daher… - Journal of the …, 2023 - Am Heart Assoc
Background Residual risk of cardiovascular events and plaque progression remains despite
reduction in low‐density lipoprotein cholesterol. Factors contributing to residual risk remain …
reduction in low‐density lipoprotein cholesterol. Factors contributing to residual risk remain …
Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study
Y Xie, GS Mintz, J Yang, H Doi, A Iñiguez… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The aim of this study was to report the frequency, patient and lesion-related
characteristics, and outcomes of subclinical, nonculprit plaque ruptures in the PROSPECT …
characteristics, and outcomes of subclinical, nonculprit plaque ruptures in the PROSPECT …
Subclinical carotid atherosclerosis: short-term natural history of lipid-rich necrotic core—a multicenter study with MR imaging
Purpose To use magnetic resonance (MR) imaging to examine the short-term (6 months)
natural history of the lipid-rich necrotic core (LRNC) in carotid artery plaques by examining …
natural history of the lipid-rich necrotic core (LRNC) in carotid artery plaques by examining …
The goal of achieving atherosclerotic plaque regression with lipid-lowering therapy: insights from IVUS trials
H Daida, T Dohi, Y Fukushima, H Ohmura… - … of Atherosclerosis and …, 2019 - jstage.jst.go.jp
Atherosclerosis has been classified as the biggest health-care issue around the world1).
Indeed, global health statistics have shown that atherosclerotic cardiovascular disease is the …
Indeed, global health statistics have shown that atherosclerotic cardiovascular disease is the …
Progression of whole-heart Atherosclerosis by coronary CT and major adverse cardiovascular events
AR van Rosendael, FY Lin, IJ van den Hoogen… - Journal of …, 2021 - Elsevier
Background The current study aimed to examine the independent prognostic value of whole-
heart atherosclerosis progression by serial coronary computed tomography angiography …
heart atherosclerosis progression by serial coronary computed tomography angiography …
Familial Hypercholesterolemia: Challenges for a High-Risk Population: JACC Focus Seminar 1/3
D Choi, WA Malick, W Koenig, DJ Rader… - Journal of the American …, 2023 - jacc.org
The availability of statins, ezetimibe, and PCSK9 inhibitors has significantly improved the
prognosis of familial hypercholesterolemia (FH). However, a great number of individuals …
prognosis of familial hypercholesterolemia (FH). However, a great number of individuals …
Swine disease models for optimal vascular engineering
Swine disease models are essential for mimicry of human metabolic and vascular
pathophysiology, thereby enabling high-fidelity translation to human medicine. The …
pathophysiology, thereby enabling high-fidelity translation to human medicine. The …
“In vivo” imaging of atherosclerosis
Atherosclerosis is a systemic and multifocal disease, which starts early in life, and that
usually takes decades before overt disease eventually appears as a consequence of …
usually takes decades before overt disease eventually appears as a consequence of …